Automated Drug Compounding Systems Sector Forecast Shows Robust Momentum, Climbing to $3.28 Billion With 12% CAGR

Uncover key drivers, emerging technologies, and competitive movements shaping the automated drug compounding systems market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Automated Drug Compounding Systems Market in 2026, and what figure is it projected to hit by 2030?

The automated drug compounding systems market size has demonstrated rapid expansion in recent years. It is anticipated to grow from $1.85 billion in 2025 to $2.08 billion in 2026, at a compound annual growth rate (CAGR) of 12.3%. This historical growth can be ascribed to the increasing integration of automated systems within hospital pharmacies, the growing necessity to minimize medication errors, a heightened focus on sterile and accurate drug preparation, the increasing workload burden on pharmacy staff, and the rising demand for efficient compounding processes that save time.

The automated drug compounding systems market is projected to experience swift expansion over the coming years, reaching a valuation of $3.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is fueled by several factors, including heightened investment in healthcare automation, greater incorporation of software and automation tools, the escalating demand for standardization in drug compounding, an increased emphasis on minimizing contamination risks, expanded hospital expenditure on automation infrastructure, and the urgent requirement for enhanced operational efficiency within pharmacies. Key trends expected during this period encompass developments in robotic-assisted drug compounding technologies, novel approaches to software integration for pharmacy management, the incorporation of artificial intelligence to reduce errors in compounding procedures, enhancements in real-time monitoring and quality control mechanisms, and breakthroughs in automated sterile compounding methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30527&type=smp

Which Drivers Are Affecting Market Participation In The Automated Drug Compounding Systems Market?

The expanding occurrence of chronic illnesses is anticipated to boost the future expansion of the automated drug compounding systems market. These are enduring health conditions, like diabetes, heart disease, and arthritis, which typically develop gradually and necessitate continuous medical care and lifestyle adjustments to manage symptoms and avert complications. Their rise is primarily linked to unhealthy lifestyle choices, such as poor diet, lack of physical activity, and smoking, which elevate the likelihood of conditions including diabetes, heart disease, and obesity. Automated drug compounding systems assist in managing chronic diseases by accurately preparing personalized medications for individual patient requirements. They enhance the precision and uniformity of treatment, thereby minimizing errors and improving long-term therapeutic results. For example, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) had been diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, insufficient for a diabetes diagnosis) in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the growing incidence of chronic diseases is propelling the expansion of the automated drug compounding systems market. The scarcity of trained pharmacy personnel is projected to drive the future growth of the automated drug compounding systems market. This refers to the restricted availability of qualified pharmacists and technicians who can safely prepare and dispense medications within hospitals, clinics, and compounding pharmacies. The increase in this shortage stems from rising patient numbers and the expanding incidence of chronic diseases, which demand meticulous pharmaceutical care. Automated drug compounding systems lessen the dependency on skilled pharmacy staff by facilitating the accurate, consistent, and efficient preparation of medications with minimal human involvement, thereby decreasing errors and the workload for pharmacy personnel. For instance, in August 2024, the National Center for Health Workforce Studies, a US-based health workforce research organization, projected a deficit of 4,980 pharmacists over the ensuing 15 years until 2036. Simultaneously, the general demand for pharmacists is anticipated to increase by 3% from 2022 to 2032, which, combined with decreasing application trends, raises significant concerns. Consequently, the insufficient number of skilled pharmacy staff is stimulating the growth of the automated drug compounding systems market.

What Segment Categories Are Covered In The Automated Drug Compounding Systems Market?

The automated drug compounding systems market covered in this report is segmented –

1) By Product: Robotic Compounding Systems, Automated Liquid Compounding Systems, Tablet And Capsule Dispensers, Injectable Compounding Robots, IV Admixture Systems, Oral Liquid Compounding Systems

2) By Component: Equipment, Software, Consumables, Services

3) By Technology: Robotic-Based Systems, Semi-Automated Systems, Gravimetric Dosing Systems, Volumetric Dosing Systems, Hybrid Dosing Systems

4) By End-User: Hospitals, Clinics, Retail Pharmacies, Compounding Pharmacies, Pharmaceutical Manufacturers

Subsegments:

1) By Robotic Compounding Systems: Fully Automated Sterile Compounding Robots, Hazardous Drug Compounding Robots, Non-Hazardous Drug Compounding Robots, High-Throughput Pharmacy Robots, Closed-System Robotic Compounding Units

2) By Automated Liquid Compounding Systems: Large-Volume Parenteral (LVP) Compounding Systems, Small-Volume Parenteral (SVP) Compounding Systems, Multi-Drug Liquid Compounding Units, Volumetric And Gravimetric Liquid Compounding Systems, Pediatric Liquid Dosing Compounding Systems

3) By Tablet and Capsule Dispensers: Automated Tablet Counting Dispensers, Unit-Dose Packaging Systems, Multi-Dose Blister Dispensing Units, Capsule Filling and Dispensing Systems, High-Speed Pharmacy Dispensing Robots

4) By Injectable Compounding Robots: Chemotherapy Drug Compounding Robots, TPN (Total Parenteral Nutrition) Compounding Robots, High-Precision Syringe Preparation Robots, Sterile Injectable Filling Robots, Hazardous Injectable Handling Systems

5) By IV Admixture Systems: Automated IV Bag Filling Systems, IV Nutrition (TPN) Admixture Systems, IV Antibiotic Admixture Devices, Pharmacy Cleanroom IV Automation Units, Closed-System IV Compounding Systems

6) By Oral Liquid Compounding Systems: Pediatric Oral Liquid Compounding Machines, Flavoring & Suspension Mixing Systems, Multi-Ingredient Oral Liquid Compounding Units, Gravimetric Oral Solution Compounding Systems, Low-Volume Oral Dosing Compounding Systems

Which Trends Are Shaping Activity Within The Automated Drug Compounding Systems Market?

Leading companies within the automated drug compounding systems market are concentrating on creating sophisticated systems, such as total parenteral nutrition (TPN) automation systems, aimed at boosting the precision, safety, and operational speed in producing tailored intravenous formulations. A total parenteral nutrition (TPN) automation system is defined as a compounding platform that not only manages the automated blending and dispensing of total parenteral nutrition (TPN) solutions but also incorporates prescription verification and workflow management features to minimize human error and guarantee aseptic, superior quality preparation. For example, in May 2025, MediServ Co. Ltd., introduced the APEX TPN Compounding System in Riyadh, marking a fresh epoch of exactness and automation for parenteral nutrition processes. The system, presented alongside its EasyComp integration software, improves the total parenteral nutrition (TPN) procedure by connecting validated prescriptions directly to sterile, precise compounding, thereby simplifying pharmacy tasks and decreasing manual efforts.

Which Major Industry Participants Are Leading The Automated Drug Compounding Systems Market Growth?

Major companies operating in the automated drug compounding systems market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc., Omnicell Inc., Eckert & Ziegler SE, Swisslog Healthcare AG, EQUASHIELD Medical Ltd., Trasis S.A., Loccioni Group S.p.A., ARxIUM Inc., Comecer S.p.A., Tema Sinergie S.p.A., Epic Medical Pte. Ltd., IBA Radiopharma Solutions S.A., Steriline S.r.l., Elysia-Raytest GmbH, Curifylabs OY, Kapsam Health Solutions Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/automated-drug-compounding-systems-market-report

Which Region Is Expected To Experience The Fastest Growth In The Automated Drug Compounding Systems Market?

North America was the largest region in the automated drug compounding Systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated drug compounding systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Automated Drug Compounding Systems Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30527&type=smp

Browse Through More Reports Similar to the Global Automated Drug Compounding Systems Market 2026, By The Business Research Company

Automated Compounding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

drug formulation global market report

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795